Lipotalon

Dexamethasone Palmitate, the active ingredient in Lipotalon, is a corticosteroid presented as a sterile injectable formulation for infiltration, intra‑articular and peri‑articular use. It is employed to reduce local inflammation and modulate immune responses in musculoskeletal sites. GNH USA supplies Lipotalon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lipotalon, a glucocorticoid used via local injection, acts on inflammatory pathways in joint‑related conditions. - Osteoarthritis: diminishes synovial inflammation and pain after intra‑articular administration. - Rheumatoid arthritis: reduces joint swelling and improves mobility when injected peri‑articularly. - Bursitis: alleviates bursal inflammation and discomfort following infiltration. - Post‑operative joint inflammation: controls acute postoperative swelling and pain in the treated area.

Adverse reactions may occur after local corticosteroid injection.

Common Side Effects: - Pain or tenderness at the injection site - Transient flushing or warmth - Mild elevation of blood glucose - Localised swelling or bruising - Headache - Temporary increase in blood pressure

Serious or Rare Side Effects: - Adrenal axis suppression - Severe or systemic infection - Osteonecrosis of the bone - Allergic reaction or anaphylaxis - Tissue atrophy or depigmentation - Hyperglycaemic crisis in diabetic patients

Careful assessment and monitoring are required when using Lipotalon. - Infection risk: evaluate for active infection before injection. - Blood glucose: monitor diabetic patients closely for hyperglycaemia. - Dose minimisation: use the lowest effective amount to achieve therapeutic effect. - Systemic effects: be aware of possible systemic glucocorticoid exposure, especially with repeated injections. - Contraindications: avoid in patients with uncontrolled systemic fungal infections. - Store at ambient temperature: keep in original packaging, protect from moisture and direct light.

Lipotalon may interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic corticosteroid exposure. - Live vaccines: risk of reduced vaccine efficacy and infection. - Anticoagulants (e.g., warfarin): heightened bleeding tendency. - Systemic antifungal agents (e.g., fluconazole): may potentiate glucocorticoid effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal ulcer risk. - Antidiabetic agents (insulin, oral hypoglycemics): may require dose adjustment due to hyperglycaemia. - ACE inhibitors or ARBs: possible additive effect on blood pressure.